AGX811

SARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, 612

suitable for immunodiffusion

• Synonym(s): 2019-nCoV, COVID-19
• UNSPSC Code: 51201600
• NACRES: NA.26

Properties

• form: liquid
• Quality Level: 100
• mol wt: ≤48 kDa
• storage condition: avoid repeated freeze/thaw cycles
• technique(s): immunodiffusion: suitable; lateral flow assay: suitable
• shipped in: dry ice

Description

General description

SARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, expressed in E.coli, Cat. No. AGX811 is for use in Lateral Flow Assay.

Target description

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleoprotein antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV)."

Physical form

Purified protein in 10mM Phosphate Buffered Saline without preservatives, pH 7.4.

Reconstitution

Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Storage and Stability

Stable for 1 year at -10°C to -25°C from date of receipt. Avoid repeated freeze/thaw cycles.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Safety Information

• Storage Class Code: 12 - Non Combustible Liquids
• WGK: WGK 2
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable